ICRISAT Secured CRISPR-Cas9 License for Global Crops
The humanitarian agreement enables the deployment of gene-edited crops across Asian and African smallholder farms.
Updated on Oct. 14, 2026 in Biotech
Live Poll
Do you believe gene editing in agriculture will ultimately improve global food security?
The International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) has secured a humanitarian licensing agreement for CRISPR-Cas9 technology from Corteva and The Broad Institute. This deal authorizes research and product development for critical crops in Asia and Africa.
Why it matters
By integrating genomic expertise into existing seed systems, the partnership aims to strengthen food security and improve livelihoods for smallholder farmers. The move provides a pathway to scale resilient crop varieties across regions vulnerable to climate stress.
The agreement grants rights to use CRISPR-Cas9 for developing improved varieties of pulses, millets, oilseeds, sorghum, pearl millet, chickpea, pigeonpea, and groundnut. This expands research capabilities beyond conventional breeding methods currently in use.
The players
ICRISAT
The International Crops Research Institute for the Semi-Arid Tropics, a research organization focused on agricultural development for smallholder farmers.
Corteva
A major agricultural chemical and seed company that holds significant intellectual property rights for gene-editing technologies.
The Broad Institute
A collaborative research center between Harvard and MIT that is a central holder of foundational CRISPR-Cas9 patents.
The details
Gene editing uses CRISPR-Cas9—a molecular tool that acts as a pair of genetic scissors to make precise changes to an organism's DNA—to develop plants with enhanced traits. The agreement allows ICRISAT to integrate this genomic capability with its established breeding programs, specifically targeting improved tolerance to heat, drought, pests, and disease.
Timeline
October 14, 2026: The licensing agreement for CRISPR-Cas9 technology was announced.
The Tech Race
This agreement marks a significant expansion of humanitarian licensing models that provide global research institutions access to proprietary gene-editing platforms. It follows a trend of patent holders granting non-commercial usage rights to accelerate crop resilience research in the Global South.
Smallholder farmers in Asia and Africa will gain access to crops specifically engineered for local environmental stresses. These improved varieties aim to stabilize yields, though their reach will depend on the speed of ICRISAT's integration into regional seed distribution networks.
The takeaway
The partnership creates a pipeline for modern genomic tools to reach the world's most vulnerable agricultural regions. Observers should track the first distribution of these gene-edited varieties to gauge how effectively the technology scales within established seed programs.
Further reading
For more on the current state of agricultural genetics, visit Biotech.
Live Poll
Do you believe gene editing in agriculture will ultimately improve global food security?
